Elisabetta Cerbai

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 107 publications

A TRIP-nano killer silencing the pain pacemakers.

A TRIP-nano killer silencing the pain pacemakers.

Journal: The Journal of physiology

Published: April 15, 2026

Long-term mavacamten exposure reduces force and sarcomere density in a hiPSC model of hypertrophic cardiomyopathy.

Long-term mavacamten exposure reduces force and sarcomere density in a hiPSC model of hypertrophic cardiomyopathy.

Journal: Cardiovascular research

Published: February 11, 2026

2025 ESC Guidelines for the management of cardiovascular disease and pregnancy

2025 ESC Guidelines for the management of cardiovascular disease and pregnancy

Journal: Giornale italiano di cardiologia (2006)

Published: February 03, 2026

Cardiovascular pharmacotherapy in 2025.

Cardiovascular pharmacotherapy in 2025.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: December 18, 2025

Environmental risk factors and cardiovascular health.

Environmental risk factors and cardiovascular health.

Journal: European heart journal

Published: September 08, 2025

2025 ESC Guidelines for the management of cardiovascular disease and pregnancy.

2025 ESC Guidelines for the management of cardiovascular disease and pregnancy.

Journal: European heart journal

Published: August 29, 2025

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.

Journal: European journal of heart failure

Published: June 14, 2025

Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug.

Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: May 30, 2025

Cell spheroid micromechanics under large deformations.

Cell spheroid micromechanics under large deformations.

Journal: Scientific reports

Published: January 20, 2025

Correlative imaging integrates electrophysiology with three-dimensional murine heart reconstruction to reveal electrical coupling between cell types.

Correlative imaging integrates electrophysiology with three-dimensional murine heart reconstruction to reveal electrical coupling between cell types.

Journal: Nature cardiovascular research

Published: January 10, 2025

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024.

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: December 16, 2024

Stable expression of SARS-CoV-2 envelope viroporin promotes intracellular calcium depletion in human cells: relevance for endoplasmic reticulum stress, cell proliferation, pluripotency and lineage differentiation.

Stable expression of SARS-CoV-2 envelope viroporin promotes intracellular calcium depletion in human cells: relevance for endoplasmic reticulum stress, cell proliferation, pluripotency and lineage differentiation.

Journal: Cell calcium

Published: November 27, 2024

Showing 1-12 of 107

Last Updated: 09/26/2026